Metraipolis › archive › dc_dda0a67f97e0
Do CVID patients on SCIG have more autoimmune (thrombo)cytopenic events than CVID patients on IVIG? — Europe PMC PMID:41394859
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41394859
- DOI
- 10.3389/fimmu.2025.1708813
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T05:04:54.799Z
- SHA-256 of the archived text
51a39bcdb19700fcdc22b2873ce4df8f4bc5a3c1e2888a9d17f5bccb263659fd- Stable URL of this page
https://metraipolis.com/documento/dc_dda0a67f97e0
How to cite
Do CVID patients on SCIG have more autoimmune (thrombo)cytopenic events than CVID patients on IVIG? — Europe PMC PMID:41394859 — Europe PMC (en), https://europepmc.org/article/MED/41394859 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dda0a67f97e0 (Metraipolis archive dc_dda0a67f97e0, sha256 51a39bcdb19700fcdc22b2873ce4df8f4bc5a3c1e2888a9d17f5bccb263659fd)
BibTeX
@misc{dcdda0a67f97e0,
title = {Do CVID patients on SCIG have more autoimmune (thrombo)cytopenic events than CVID patients on IVIG? — Europe PMC PMID:41394859},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41394859},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dda0a67f97e0; sha256 51a39bcdb19700fcdc22b2873ce4df8f4bc5a3c1e2888a9d17f5bccb263659fd},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41394859. Agents can read the archived copy with the MCP tool read_document.